Cramer’s lightning round: Let Extreme Networks cool off a little before buying

Cramer’s lightning round: Let Extreme Networks cool off a little before buying


Paramount Group Inc: “It is very inexpensive, but at the same time, I don’t like office real estate. So, I am torn on it.”

Uranium Energy Corp: “There are no consistent brands right now in this country for nuclear power. It has too many enemies.”

Extreme Networks Inc: “I think it’s a very good networking company. … Let it cool off a little, and then you can do some buying.”

Super Micro Computer Inc: “It seems too good to be true, which means we have to … figure out exactly what that company does.”

Nvidia Corp: “I think [their inventory buildup] goes through and is done and is flushed by the first weeks of January, and will be in better shape.”

Barrick Gold Corp: “It’s got a good yield, but the problem is, is that the dollar’s got to get weaker. And in that case, if the chart is good, you can be a buyer.”

Disclaimer: Cramer’s Charitable Trust owns shares of Nvidia.

Cramer's lightning round: Let Extreme Networks cool off a little before buying

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More